CDMO for regenerative medicine tissue products and biologics
Evergen is a contract manufacturer of regenerative medicine biologics—allograft, xenograft, and engineered tissue products for orthopedics, cardiac, and neurosurgery. The hiring mix is heavily manufacturing and operations focused (28 of 44 open roles), with active projects spanning tissue yield optimization, process characterization, and MRP development, while simultaneously migrating from SAP to NetSuite—a transition that appears to be a near-term operational priority given it appears explicitly in their pain-point list.
Notable leadership hires: Quality Director
Evergen is a privately held CDMO based in Alachua, Florida, founded in 1998 and currently staffed across 501–1,000 employees. The company develops and manufactures biological materials—including SIS, allograft, and xenograft products—for OEM partners serving plastic and reconstructive surgery, sports medicine, orthopedics, cardiac, and neurosurgery segments. Their business model centers on identifying clinical problems for OEMs and manufacturing customized tissue-based solutions at scale. Manufacturing and operations dominate their workforce, supported by engineering, quality, and commercial functions.
Evergen's operational tech spans Microsoft Office, Excel, NetSuite (ERP), SAP BusinessObjects (analytics), Power BI, and specialized manufacturing software including CNC, HPLC, and LIMS for laboratory and production automation.
Active projects include tissue yield optimization, process characterization, validation protocol development, commercial funnel management, and materials resource planning (MRP) system development alongside a transition from SAP to NetSuite.
Other companies in the same industry, closest in size